Healthcare
M&A Advisory
Technology
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Insmed. United States. Announced Date 16/07/2013. Closed Date 22/07/2013. Deal value: $62m. Common stock. Industry: Insmed is a biopharmaceutical company focused on developing therapies for rare diseases.